Understanding ADHD: Jay and Rosie Glazer’s Journey
Supernus Pharmaceuticals has recently unveiled an engaging video series featuring TV personality Jay Glazer and his wife, Rosie Glazer, shedding light on the nuances of ADHD and how it affects their relationship. This collaboration aims to bring awareness and understanding to ADHD, especially in the context of living with a partner facing this challenge. The series premiered on the All About ADHD YouTube channel during Mental Health Awareness Month.
The Impact of ADHD on Relationships
In this four-part series, Jay and Rosie share their personal experiences, highlighting how ADHD shapes their dynamic as a couple. They delve into the unique challenges they face and the small victories that have come from their journey together. By opening up about their experiences, they hope to resonate with others who may be navigating similar circumstances.
A Candid Conversation
“Rosie has been an incredible support system throughout my ADHD journey,” says Jay. His heartfelt sentiments reflect a key message of the series: the importance of open communication. He stresses that acknowledging ADHD’s effects not only helps the individual but also strengthens the bond with loved ones. With the help of Qelbree, a non-stimulant medication approved for those aged six years and older, Jay discusses practical strategies he has embraced to manage his condition effectively.
Navigating Challenges Together
The series is designed to spark meaningful discussions about ADHD symptoms and treatment options while encouraging viewers to engage in support networks. Rosie provides insight into her supportive role, illustrating how couples can work as a team in dealing with ADHD. This collaboration between Jay and Rosie serves as an example of how understanding and support can lead to better management of symptoms.
Expert Insights from Supernus Pharmaceuticals
Jack Khattar, the President and CEO of Supernus Pharmaceuticals, notes how the series emphasizes ADHD's widespread impact. “It impacts not only the individual but also their support system, which can sometimes include the people closest to them,” he explains. Khattar expresses gratitude for the Glazer's willingness to share their story. These shared experiences reinforce Supernus's commitment to fostering a well-informed community and providing effective treatment solutions for those battling ADHD.
Qelbree: A Closer Look
Qelbree (viloxazine extended-release capsules) is a prescription medication used to treat ADHD in both adults and children. It is essential for patients to consult with healthcare providers to discuss all medications being taken and to determine if Qelbree is appropriate for them. Side effects range from mood changes to lethargy, so patients must be monitored closely during treatment.
Essential Information about Qelbree
Qelbree has been made available in different dosages, including 100 mg, 150 mg, and 200 mg capsules, allowing for tailored treatment options. Moreover, it’s critical for those who are considering Qelbree to understand potential risks, including increased blood pressure, heart rate, and the possibility of manic episodes for individuals with a history of bipolar disorder.
About Supernus Pharmaceuticals
Supernus Pharmaceuticals is dedicated to developing and commercializing innovative products that target central nervous system (CNS) disorders such as ADHD and others. With a diverse portfolio, they are focused on bringing forth new treatments for conditions like epilepsy and depression. The Glazer series amplifies their mission, as they continue to prioritize the health and well-being of individuals living with these conditions.
Frequently Asked Questions
What is the aim of the Jay and Rosie Glazer series?
The series aims to raise awareness about ADHD and its impact on relationships while providing insights into treatment options like Qelbree.
How does ADHD affect relationships according to Jay and Rosie?
Jay and Rosie emphasize that ADHD impacts both individuals and their partners, highlighting the importance of communication and support.
What role does Qelbree play in Jay's treatment?
Qelbree is a critical component of Jay's ADHD management plan, helping him navigate his symptoms effectively.
Why is the series important for the ADHD community?
It encourages open discussions about ADHD, making it relatable for individuals and their families and promoting a supportive community.
Who is Supernus Pharmaceuticals?
Supernus Pharmaceuticals is a biopharmaceutical company specializing in developing treatments for CNS disorders, focusing on ADHD and other related conditions.
